Relationship of triple dose contrast enhanced lesions with clinical measures and brain atrophy in early relapsing-remitting multiple sclerosis: a two-year longitudinal study.

Rashid, W; Davies, GR; Chard, DT; Griffin, CM; Altmann, DR; Thompson, AJ; Miller, DH; (2007) Relationship of triple dose contrast enhanced lesions with clinical measures and brain atrophy in early relapsing-remitting multiple sclerosis: a two-year longitudinal study. Multiple sclerosis (Houndmills, Basingstoke, England), 13 (2). pp. 178-85. ISSN 1352-4585 DOI: https://doi.org/10.1177/1352458506070758

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1177/1352458506070758

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar